Cite
MLA Citation
S Noack et al.. “P483 Infliximab but not adalimumab drug levels predict faecal calprotectin response in Inflammatory Bowel Disease patients on dose-intensified anti-TNF therapy.” Journal of Crohn's and colitis, vol. 15, n.d., pp. S471–S472. http://access.bl.uk/ark:/81055/vdc_100130765214.0x00001c